Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday? [Yahoo! Finance]
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $12.00 price target on the stock, down previously from $17.00.